Haemonetics price to free cash flow HAE

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 18.5×
10-year median: 36.8×
Against its 10-year history: 12th; percentile: 0 is its lowest day, 100 its highest
10-year range: 8.2× to 180×
Peer median: 27.3×

Haemonetics' price to free cash flow is 18.5× as of Oct 23, 2026.

That is below its ten-year median of 36.8×, lower than on 88% of days in the last ten years.

Over that time it ranged from 8.2× in Mar 2026 to 180× in Aug 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 27.3×.

Price to free cash flow over time

median 36.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	18.5×	8.2×	18.5×
2025	14.7×	12.3×	106×
2024	103×	19.4×	118×
2023	21.8×	20.9×	38.9×
2022	34.2×	34.1×	99.7×
2021	50.3×	24.2×	73.1×
2020	50.4×	33.9×	116×
2019	116×	58.2×	180×
2018	60.5×	26.8×	70.5×
2017	24.8×	21.8×	34.9×
2016	34.0×	32.9×	91.8×
2015	93.6×	74.5×	447×
2014	77.6×	66.4×	77.6×
2013	71.3×	65.3×	101×
2012	63.3×	18.1×	64.9×
2011	17.9×	15.9×	23.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Haemonetics' size, closest first, today.

Company	Price to free cash flow
HAEHaemonetics	18.5×
MMSIMerit Medical Systems	27.4×
VNTVontier	12.1×
BMIBadger Meter	29.2×
ICUIICU Medical	27.3×
MSAMSA Safety	19.8×
NVSTEnvista	15.3×
WRBYWarby Parker	147×
ATRCAtriCure	56.5×
PODDInsulet	35.2×
GMEDGlobus Medical	14.5×
Peer median	27.3×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Haemonetics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.